Avantor, Inc. Loss Contingency Accrual, Provision
Avantor, Inc. (AVTR) reported Loss Contingency Accrual, Provision of $400.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LossContingencyAccrualProvision · last filed 2026-04-29
- Avantor, Inc. loss contingency accrual, provision for the quarter ending 2026-03-31 was $400.00K.
- Avantor, Inc. loss contingency accrual, provision for the quarter ending 2025-12-31 was $2.10M, a 61.54% increase year-over-year.
- Avantor, Inc. loss contingency accrual, provision for the quarter ending 2025-09-30 was $1.60M, a 79.75% decline year-over-year.
- Avantor, Inc. loss contingency accrual, provision for the quarter ending 2025-06-30 was $3.60M.
- Avantor, Inc. loss contingency accrual, provision for fiscal 2025 was $7.30M, a 20.65% decline from fiscal 2024.
- Avantor, Inc. loss contingency accrual, provision for fiscal 2024 was $9.20M, a 29.58% increase from fiscal 2023.
- Avantor, Inc. loss contingency accrual, provision for fiscal 2023 was $7.10M.
- Avantor, Inc. loss contingency accrual, provision for fiscal 2022 was $0.00.
| Period end | Loss Contingency Accrual, Provision 3 month | Loss Contingency Accrual, Provision 6 month | Loss Contingency Accrual, Provision 9 month | Loss Contingency Accrual, Provision 12 month |
|---|---|---|---|---|
| 2026-03-31 | $400.00K 10-Q · filed 2026-04-29 | $2.50M derived: sum of 2 quarters · filed 2026-04-29 | $4.10M derived: sum of 3 quarters · filed 2026-04-29 | $7.70M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $3.70M derived: sum of 2 quarters · filed 2026-02-11 | $7.30M derived: sum of 3 quarters · filed 2026-02-11 | $7.30M 10-K · filed 2026-02-11 |
| 2025-09-30 | $1.60M 10-Q · filed 2025-10-29 | $5.20M derived: sum of 2 quarters · filed 2025-10-29 | $5.20M 10-Q · filed 2025-10-29 | $6.50M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $3.60M 10-Q · filed 2025-08-01 | $3.60M 10-Q · filed 2025-08-01 | $4.90M derived: sum of 3 quarters · filed 2026-04-29 | $12.80M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $0.00 10-Q · filed 2026-04-29 | $1.30M derived: sum of 2 quarters · filed 2026-04-29 | $9.20M derived: sum of 3 quarters · filed 2026-04-29 | $9.20M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $9.20M derived: sum of 2 quarters · filed 2026-02-11 | $9.20M derived: sum of 3 quarters · filed 2026-02-11 | $9.20M 10-K · filed 2026-02-11 |
| 2024-09-30 | $7.90M 10-Q · filed 2025-10-29 | $7.90M derived: sum of 2 quarters · filed 2025-10-29 | $7.90M 10-Q · filed 2025-10-29 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-01 | $0.00 10-Q · filed 2025-08-01 | ||
| 2023-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $6.10M derived: sum of 2 quarters · filed 2026-02-11 | $7.10M derived: sum of 3 quarters · filed 2026-02-11 | $7.10M 10-K · filed 2026-02-11 |
| 2023-09-30 | $3.00M 10-Q · filed 2023-10-27 | $4.00M derived: sum of 2 quarters · filed 2023-10-27 | $4.00M 10-Q · filed 2023-10-27 | |
| 2023-06-30 | $1.00M 10-Q · filed 2023-07-28 | $1.00M 10-Q · filed 2023-07-28 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $0.00 derived: sum of 2 quarters · filed 2025-02-07 | $0.00 derived: sum of 3 quarters · filed 2025-02-07 | $0.00 10-K · filed 2025-02-07 |
| 2022-09-30 | $0.00 10-Q · filed 2023-10-27 | $0.00 derived: sum of 2 quarters · filed 2023-10-27 | $0.00 10-Q · filed 2023-10-27 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-07-28 | $0.00 10-Q · filed 2023-07-28 | ||
| 2021-12-31 | $0.00 10-K · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |